Zhao, K., Karimi, A., Kelly, L., Petre, E., Marinelli, B., Alexander, E. S., . . . Yarmohammadi, H. (2025). TP53 Mutation Predicts Worse Survival and Earlier Local Progression in Patients with Hepatocellular Carcinoma Treated with Transarterial Embolization. Current Oncology, 32(1), 51. https://doi.org/10.3390/curroncol32010051
Chicago Style (17th ed.) CitationZhao, Ken, et al. "TP53 Mutation Predicts Worse Survival and Earlier Local Progression in Patients with Hepatocellular Carcinoma Treated with Transarterial Embolization." Current Oncology 32, no. 1 (2025): 51. https://doi.org/10.3390/curroncol32010051.
MLA (9th ed.) CitationZhao, Ken, et al. "TP53 Mutation Predicts Worse Survival and Earlier Local Progression in Patients with Hepatocellular Carcinoma Treated with Transarterial Embolization." Current Oncology, vol. 32, no. 1, 2025, p. 51, https://doi.org/10.3390/curroncol32010051.